Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 2
1(25.0%)
4Total
N/A(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06411197Not ApplicableRecruiting

Exploration of Gait Biomechanics and Muscle Pain of the Lower Extremity

Role: lead

NCT06330402Not ApplicableCompleted

Exploration of Gait Biomechanics and Pain

Role: lead

NCT04224584Phase 2Completed

A Mechanism Based Proof of Concept Study of the Effects of Duloxetine in the Treatment of Patients With Osteoarthritic Knee Pain

Role: lead

NCT03718663Completed

Predictors for Analgesic Effect to Standardized Exercise Therapy for Osteoarthritic Pain

Role: lead

NCT02808611Not ApplicableCompleted

Influence of Propranolol on Conditioned Pain Modulation

Role: lead

All 5 trials loaded